IN VITRO–IN VIVO SCALE-UP OF DRUG TRANSPORT ACTIVITIES - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 582

3. Giacomini, K.M. and Sugiyama, Y. (2006). Membrane transporters and drug response.
In: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed., ed. by
Brunton, L.L., McGraw-Hill, New York, pp. 41-70.
4. Kusuhara, H. and Sugiyama, Y. (2001). Drug-drug interactions involving the membrane
transport process. In: Drug-Drug-Interactions , ed. by Rodrigues, A.D., Marcel Dekker,
Basel, Switzerland, pp. 123-188.
5. Yamazaki, M., Suzuki, H., Hanano, M. and Sugiyama, Y. (1993). Different relationships
between cellular ATP and hepatic uptake among taurocholate, cholate, and organic anions.
Am J Physiol 264, G693-G701.
6. Shitara, Y., Li, A.P., Kato, Y., Lu, C., Ito, K., Itoh, T. and Sugiyama, Y. (2003). Function of
uptake transporters for taurocholate and estradiol 17beta-D-glucuronide in cryopreserved
human hepatocytes. Drug Metab Pharmacokinet 18, 33-41.
7. Hirano, M., Maeda, K., Shitara, Y. and Sugiyama, Y. (2004). Contribution of OATP2
(OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
J Pharmacol Exp Ther 311, 139-146.
8. Jigorel, E., Le Vee, M., Boursier-Neyret, C., Bertrand, M. and Fardel, O. (2005). Functional
expression of sinusoidal drug transporters in primary human and rat hepatocytes. Drug
Metab Dispos 33, 1418-1422.
9. Ishigami, M., Tokui, T., Komai, T., Tsukahara, K., Yamazaki, M. and Sugiyama, Y. (1995).
Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat
hepatocytes. Pharm Res 12, 1741-1745.
10. Rippin, S.J., Hagenbuch, B., Meier, P.J. and Stieger, B. (2001). Cholestatic expression
pattern of sinusoidal and canalicular organic anion transport systems in primary cultured
rat hepatocytes. Hepatology 33, 776-782.
11. Miyauchi, S., Sawada, Y., Iga, T., Hanano, M. and Sugiyama, Y. (1993). Comparison of the
hepatic uptake clearances of fifteen drugs with a wide range of membrane permeabilities
in isolated rat hepatocytes and perfused rat livers. Pharm Res 10, 434-440.
12. Kato, Y., Akhteruzzaman, S., Hisaka, A. and Sugiyama, Y. (1999). Hepatobiliary transport
governs overall elimination of peptidic endothelin antagonists in rats. J Pharmacol Exp
Ther 288, 568-574.
13. Kouzuki, H., Suzuki, H., Ito, K., Ohashi, R. and Sugiyama, Y. (1998). Contribution of
sodium taurocholate co-transporting polypeptide to the uptake of its possible substrates
into rat hepatocytes. J Pharmacol Exp Ther 286, 1043-1050.
14. Kouzuki, H., Suzuki, H., Ito, K., Ohashi, R. and Sugiyama, Y. (1999). Contribution of
organic anion transporting polypeptide to uptake of its possible substrates into rat hepato-
cytes. J Pharmacol Exp Ther 288, 627-634.
15. Crespi, C.L. and Penman, B.W. (1997). Use of cDNA-expressed human cytochrome P450
enzymes to study potential drug-drug interactions. Adv Pharmacol 43, 171-188.
16. Sekine, T., Cha, S.H., Tsuda, M., Apiwattanakul, N., Nakajima, N., Kanai, Y. and Endou, H.
(1998). Identification of multispecific organic anion transporter 2 expressed predominantly
in the liver. FEBS Lett 429, 179-182.
17. Noe, B., Hagenbuch, B., Stieger, B. and Meier, P.J. (1997). Isolation of a multispecific
organic anion and cardiac glycoside transporter from rat brain. Proc Natl Acad Sci USA
94, 10346-10350.
18. Cattori, V., Hagenbuch, B., Hagenbuch, N., Stieger, B., Ha, R., Winterhalter, K.E. and
Meier, P.J. (2000). Identification of organic anion transporting polypeptide 4 (Oatp4) as a